These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3971843

  • 1. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G, Pickup JC, Keen H.
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [Abstract] [Full Text] [Related]

  • 2. Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes--a metabolic and clinical comparison with intravenous infusion.
    Husband DJ, Marshall SM, Walford S, Hanning I, Wright PD, Alberti KG.
    Diabet Med; 1984 Jul; 1(2):99-104. PubMed ID: 6242795
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The natural history of brittle diabetes.
    Williams G, Pickup JC.
    Diabetes Res; 1988 Jan; 7(1):13-8. PubMed ID: 3042251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
    Home PD, Capaldo B, Burrin JM, Worth R, Alberti KG.
    Diabetes Care; 1982 Jan; 5(5):466-71. PubMed ID: 6765222
    [Abstract] [Full Text] [Related]

  • 14. A clinical algorithm to determine the etiology of brittle diabetes.
    Schade DS, Eaton RP, Drumm DA, Duckworth WC.
    Diabetes Care; 1985 Jan; 8(1):5-11. PubMed ID: 3882369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P, Ojeda Rodríguez S, Corrales Hernández JJ, Mories Álvarez MT, Recio Córdova JM, Delgado Gómez M, Sánchez Marcos AI, Iglesias López RA, Herrero Ruiz A, Beaulieu Oriol M, Miralles García JM.
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [Abstract] [Full Text] [Related]

  • 17. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S, Smith-Palmer J, Valentine WJ, Cook M, Jethwa M, de Portu S, Pickup JC.
    J Med Econ; 2016 Mar; 19(3):236-42. PubMed ID: 26510389
    [Abstract] [Full Text] [Related]

  • 18. Diurnal variation in carbohydrate tolerance to mixed meal in insulin-dependent diabetic adolescents during continuous intravenous insulin infusion (CIVII).
    Rewers M, Dmochowski K, Walczak M.
    Endokrynol Pol; 1985 Mar; 36(1):1-7. PubMed ID: 4042995
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C, Pleus S, Wiegel C, Schiltges G, Jendrike N, Haug C, Freckmann G.
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.